Amanote Research
Register
Sign In
Differential Effects of Two Pharmaceutical Cost Containment Policies on Outpatient Prescription Drug Expenditures in Korea
Value in Health
- United Kingdom
doi 10.1016/j.jval.2014.03.089
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2014
Authors
S. Park
E. Han
N.S. Kim
S.M. Chae
C. Ryu
Publisher
Elsevier BV
Related search
Pharmaceutical Cost-Containment Policies and Sustainability: Recent Irish Experience
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Impact of Pharmaceutical Rebates on Patients’ Drug Expenditures
CMAJ
Medicine
Do State Cost Control Policies Reduce Medicaid Prescription Drug Spending?
Risk Management and Insurance Review
Accounting
Economics
Econometrics
Finance
Medicaid Cost Containment and Access to Prescription Drugs
Health Affairs
Medicine
Health Policy
Effects of Drug Price Reduction and Prescribing Restrictions on Expenditures and Utilisation of Antihypertensive Drugs in Korea
BMJ Open
Medicine
The Effects of Urban Containment Policies on Commuting Patterns
Effects of Different Mark-Up Drug Policies on Drug-Related Expenditures in Tertiary Public Hospitals: An Interrupted Time Series Study in Shanghai, China, 2015-2018
BioScience Trends
Biochemistry
Health
Medicine
Genetics
Molecular Biology
PHP149 Perception of Pharmaceutical Companies on the Drug Price-Volume Negotiation in South Korea
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Demand Effects of Recent Changes in Prescription Drug Promotion